Drug-based Services - CD BioSciences


Drug-based Services

Drug-based Services

Drug discovery is the process to identify potential therapeutic drugs for diseases of interest. It involves the identification of druggable target, compound screening, hit evaluation and optimization, and preclinical studies.

Signaling pathways regulate cellular activities such as immune response, metabolism, and cell proliferation. Malfunction of signaling pathways often leads to pathological or disease states, such as immunological diseases, cancers, diabetes, and neurodegenerative diseases. Thus, regulators in signaling pathways are drug targets of great potentials.

CD BioSciences offers a complete panel of drug-based services to identify potential medicines and understand their mechanism of actions (MOAs).

Drug discovery process

Drug-base services

Drug Screening

Drug-base services

Target Identification

Drug screening is to identify compounds that are promising for drug development before preclinical and clinical trials.

CD BioSciences designs, builds and operates fast and effective compound screenings, and delivers high-quality, validated hit compounds for your drug discovery project.

Target identification is the process of identifying the direct molecular target (e.g., protein or nucleic acid) of a small molecule. It is required to fully characterize on-target and off-target effects and to understand the mechanisms of small-molecule action.

No matter that you "have a drug of efficacy but the target is unknown", or you "need to find a target for new drug discovery and development", CD BioSciences offers satisfying solutions to meet your needs.

Drug-base services

Drug Evaluation

Drug-base services

Drug Optimization

Drug-base services

Preclinical Study

Drug evaluation refers to the study of drug metabolism and pharmacokinetics (DMPK), which studies the Absorption/Administration, Distribution, Metabolism, and Elimination/Excretion (ADME) properties of chemical compounds to assist the selection of optimal drug candidates.

CD BioSciences offers a full range of services for drug candidate evaluation, including in vitro physicochemical profiling and in vivo bioassays.

Drug optimization or lead optimization aims at enhancing the chemical compounds from drug screening to improve potency, and reduce toxicity. It is one of the most important steps in drug development.

CD BioSciences offers a complete panel of drug optimization solutions to help you discover potential drugs.

Preclinical studies determine a drug's efficacy and safety and assess potential toxicity before testing it in humans. Successful preclinical studies demand experienced experts in toxicology, pathology, surgery and other related fields.

CD BioSciences offers a complete package of preclinical services to efficiently assess your drug's potential.


CD BioSciences offers cost-effect, high quality and hassle-free services to our clients worldwide. We guarantee to deliver our results on time. Please feel free to contact us.

For research use only. Not intended for any clinical use.